Updated Jul 16, 2026
Boctor Fady has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Boctor Fady is identified in the most recent SEC filing (as of 2026-06-05) in connection with Petros Pharmaceuticals, Inc. The publicly available information from the filings does not provide a clear biographical profile, background, or specific role beyond indicating that this individual appears as a named person in the SEC remarks. There is no additional corroborated biographical data from company leadership pages, investor relations materials, or other public databases available in this context. Further verification from the actual SEC filing remarks or Petros Pharmaceuticals disclosures would be needed to determine current position, background, and career history.
| Role | See Remarks |
|---|---|
| Notability | 25/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | PTPI | Petros Pharmaceuticals, Inc. | A — Grant or award | 375.0K | $0.00 |
Boctor Fady is identified in the most recent SEC filing (as of 2026-06-05) in connection with Petros Pharmaceuticals, Inc. The publicly available information from the filings does not provide a clear biographical profile, background, or specific role beyond indicating that this individual appears as a named person in the SEC remarks. There is no additional corroborated biograph…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Boctor Fady profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.